Stock listing
Annji Pharmaceutical Co., Ltd.
Selected listing: 7754 · TPEX · TWD · TW
Annji Pharmaceutical Co., Ltd. (TPEx:7754), Health Technology. Latest release Oct 5, 2026: AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD…
- Ticker
- TPEx:7754
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
About Annji Pharmaceutical Co., Ltd.
Annji Pharmaceutical Co., Ltd. is a publicly traded company on the Taiwan market under the ticker 7754. Annji aims to contribute to the healthcare industry through its research and development efforts.
Latest news from Annji Pharmaceutical Co., Ltd.
AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)
October 5, 2026
Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference
March 3, 2026
FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease
October 22, 2025
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025
October 13, 2025
Research Annji Pharmaceutical Co., Ltd.
Annji Pharmaceutical Co., Ltd. company profile
View the public company page for Annji Pharmaceutical Co., Ltd. on 6ix.
Annji Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Annji Pharmaceutical Co., Ltd..
Annji Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Annji Pharmaceutical Co., Ltd..